Page last updated: 2024-09-05

24-norursodeoxycholic acid and Cirrhosis, Liver

24-norursodeoxycholic acid has been researched along with Cirrhosis, Liver in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, HX; Liang, ZY; Qin, SY; Su, SB; Wang, F; Yan, YD; Zhangdi, HJ1
Claudel, T; Engelmann, R; Fickert, P; Fuchs, CD; Guenther, ND; Langner, C; Loebermann, M; Mueller, M; Mueller-Hilke, B; Österreicher, CH; Reisinger, EC; Sahin, E; Schramm, C; Schwinge, D; Sombetzki, M; Trauner, M1
Blomenkamp, K; Fickert, P; Marcus, N; Tang, Y; Teckman, J; Trauner, M1
He, P; Lei, JH; Wang, CX; Yuan, WG; Zhang, CY1
Beraza, N; Bischoff, SC; Boekschoten, M; Ehedego, H; Mueller, M; Ofner-Ziegenfuss, L; Trauner, M; Trautwein, C1
Fauler, G; Fickert, P; Frank, S; Guelly, C; Gumhold, J; Höfler, G; Kratky, D; Lass, A; Magnes, C; Moustafa, T; Reicher, H; Sattler, W; Silbert, D; Sinner, F; Thueringer, A; Trauner, M; Zechner, R1

Reviews

2 review(s) available for 24-norursodeoxycholic acid and Cirrhosis, Liver

ArticleYear
Crosstalk network among multiple inflammatory mediators in liver fibrosis.
    World journal of gastroenterology, 2019, Sep-07, Volume: 25, Issue:33

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hepatic Stellate Cells; Hepatocytes; Humans; Imidazoles; Inflammation; Inflammation Mediators; Liver; Liver Cirrhosis; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrimidinones; Signal Transduction; Sulfoxides; Ursodeoxycholic Acid

2019
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
    World journal of gastroenterology, 2016, Dec-28, Volume: 22, Issue:48

    Topics: Acetyl-CoA C-Acetyltransferase; Animals; CD4-Positive T-Lymphocytes; Disease Progression; Fatty Liver, Alcoholic; Hepatic Stellate Cells; Humans; Interleukins; Intracellular Signaling Peptides and Proteins; LIM Domain Proteins; Liver Cirrhosis; Macrophages; MicroRNAs; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Resveratrol; Schistosomiasis; Signal Transduction; Stilbenes; T-Lymphocytes, Regulatory; Triterpenes; Ursodeoxycholic Acid; Ursolic Acid; Virus Diseases

2016

Other Studies

4 other study(ies) available for 24-norursodeoxycholic acid and Cirrhosis, Liver

ArticleYear
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
    Journal of hepatology, 2015, Volume: 62, Issue:4

    Topics: Animals; Cholagogues and Choleretics; Disease Models, Animal; Drug Monitoring; Granuloma; Immunohistochemistry; Inflammation; Liver Cirrhosis; Lymphocyte Activation; Mice; Schistosomiasis mansoni; T-Lymphocytes; Treatment Outcome; Ursodeoxycholic Acid

2015
Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
    American journal of physiology. Gastrointestinal and liver physiology, 2016, 07-01, Volume: 311, Issue:1

    Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Animals; Autophagy; Cells, Cultured; Deoxycholic Acid; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Liver; Liver Cirrhosis; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phenotype; Transfection; Ursodeoxycholic Acid

2016
Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
    Gut, 2011, Volume: 60, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Proliferation; Diet, Fat-Restricted; Disease Progression; Down-Regulation; Drug Evaluation, Preclinical; Fatty Liver; Hepatocytes; Intracellular Signaling Peptides and Proteins; Lipids; Liver; Liver Cirrhosis; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Ursodeoxycholic Acid

2011
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
    Gastroenterology, 2012, Volume: 142, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Acids and Salts; Cell Proliferation; Cholestasis, Intrahepatic; Chronic Disease; Dietary Fats; Disease Models, Animal; Disease Progression; Fatty Acids; Female; Fenofibrate; Gene Expression Profiling; Gene Expression Regulation; Hepatitis; Hypolipidemic Agents; Lipid Metabolism; Liver; Liver Cirrhosis; Metabolomics; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Triglycerides; Ursodeoxycholic Acid

2012